Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and inspiring, because that oh-so-familiar routine of meetings, deadlines, conference calls, and whatever else has, of course, returned. So what else can we do but turn to a few cups of stimulation to cope? Our choice today is butter pecan, for those seeking ideas. Speaking of ideas, here is the latest menu of tidbits to help you on your journey today. We hope all goes well and, as always, encourage you to keep in touch. We enjoy the tips, feedback and suggestions …

Allergan (AGN) disclosed that two influential advisory firms — Institutional Shareholder Services and Glass Lewis — urged its shareholders to vote against a proposal by the Appaloosa hedge fund to immediately separate the chief executive officer and chairman roles. Appaloosa, led by billionaire David Tepper, has been pressing Allergan since last year to separate the two roles. Instead, the drug maker recently committed to separating the jobs during its next leadership transition. ISS noted Allergan added six independent directors since 2016.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy